Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Introduction and Overview of CAR T-Cell Therapy (14 mins)

This segment provides an overview of CAR T-cell therapy, including brief discussions of underlying principles and best referral practices.
Michael R. Bishop, MD
Program Director
Daniel J. DeAngelo, MD, PhD
Noopur Raje, MD
Released: August 14, 2020 Expiration: No longer available for credit

This program is divided into short segments that you can review from the Activity landing page.
PreviousNext

Related Content

Downloadable slideset from a live webinar from Clinical Care Options (CCO) on the diagnosis and staging of light-chain amyloidosis

Shaji K. Kumar, MD Released: January 18, 2022

Downloadable slideset from a live webinar from Clinical Care Options (CCO) on the initial management of light-chain amyloidosis

Vaishali Sanchorawala, MD Released: January 18, 2022

Downloadable slideset from a live webinar from Clinical Care Options (CCO) on the management of light-chain amyloidosis at relapse

Ankit Kansagra, MD Released: January 18, 2022

Ashley Leak Bryant, PhD, RN, OCN, FAAN, shares strategies for managing lower-risk myelodysplastic syndromes in this commentary from Clinical Care Options (CCO)

Ashley Leak Bryant, PhD, RN, OCN, FAAN Released: January 14, 2022

Video Chapters


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Celgene Corporation
Legend Biotech USA Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings